Key statistics
On Friday, Pacira Biosciences Inc (PCRX:NSQ) closed at 21.77, 15.80% above the 52 week low of 18.80 set on Jan 20, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 21.47 |
|---|---|
| High | 22.45 |
| Low | 21.47 |
| Bid | 15.77 |
| Offer | 22.92 |
| Previous close | 21.45 |
| Average volume | 713.46k |
|---|---|
| Shares outstanding | 41.10m |
| Free float | 40.30m |
| P/E (TTM) | 46.68 |
| Market cap | 894.75m USD |
| EPS (TTM) | 0.4664 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Pacira to Report 2025 Financial Results on Thursday February 26, 2026
- Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
More ▼
